Skip to content

Gross Profit at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$8.07B-1.2%
Pfizer logo
PfizerPFE
$10.9B+0.3%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2.59B+7.8%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$151.04M+7.1%
Incyte logo
IncyteINCY
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN

Other financials

Income statement

See full
Revenue$20.7M+138%
Operating income-$110.0M-3.2%
Net income-$99.1M-11.0%
EPS (diluted)-$1.69-9.0%

Balance sheet

See full
Cash & equivalents$113.6M+43.9%
Total debt$35.7M-32.5%
Total equity$1.1B-24.4%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow-$118.9M-6.7%
CapEx$769.0K+0.4%
Free cash flow-$119.7M-6.6%

Valuation

See full
Market cap$2.12B+18.1%
Enterprise value$2.04B+15.2%
P/S32.1×-16.4×

Profitability

See full
Gross margin90%+2.5pp
Operating margin-720%-204pp
Net margin-639.8%
FCF margin-582.5%-185pp

Returns & leverage

See full
Return on equity-32.8%
Debt / equity0.0×
Current ratio14.2×-4.3×

Where this comes from

Calculated from Agios Pharmaceuticals’s reported figures.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agios Pharmaceuticals's gross profit?
Agios Pharmaceuticals (AGIO) reported gross profit of $19.43M in Q1 2026.
How has Agios Pharmaceuticals's gross profit changed year-over-year?
Agios Pharmaceuticals's gross profit increased by 154.2% year-over-year, from $7.64M to $19.43M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.